Published in Toxicol Appl Pharmacol on January 01, 1989
THE MEASUREMENT OF SYMPATHETIC VASOCONSTRICTOR ACTIVITY IN THE LOWER EXTREMITIES. J Clin Invest (1930) 32.02
A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell (1991) 6.14
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet (1998) 4.92
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet (2000) 4.83
The heat resistance of bacterial spores at various water activities. J Gen Microbiol (1966) 4.23
A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology (1999) 4.10
Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res (1997) 3.63
Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol (1988) 3.24
A freely diffusible form of Sonic hedgehog mediates long-range signalling. Nature (2001) 2.50
Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol (2011) 2.41
Worldwide esophageal cancer collaboration. Dis Esophagus (2009) 2.41
Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther (1985) 1.98
STUDIES ON THE ACTIVITY OF THE LUMBAR SYMPATHETIC NERVOUS SYSTEM. Ann Surg (1930) 1.83
Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA (2001) 1.81
Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures. Am J Physiol (1999) 1.66
PUBLIC HEALTH ENGINEERING: SURVEY OF CONNECTICUT'S SHORE BATHING WATERS. Am J Public Health Nations Health (1932) 1.64
Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther (1994) 1.63
CHANGES IN THE VASOMOTOR REACTION ASSOCIATED WITH GLOMUS TUMORS. J Clin Invest (1937) 1.57
Determinants of cord-blood IgE concentrations in 6401 German neonates. Allergy (1995) 1.55
The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience (2005) 1.50
Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers. J Pediatr (1985) 1.49
Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos (2000) 1.49
Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci (2004) 1.44
Percutaneous transthoracic needle aspiration biopsy: a comprehensive review of its current role in the diagnosis and treatment of lung tumors. Chest (1998) 1.42
Cigarette smoke exposure and development of infants throughout the first year of life: influence of passive smoking and nursing on cotinine levels in breast milk and infant's urine. Acta Paediatr (1992) 1.41
Effects of various gases on the survival of dried bacteria during storage. Appl Microbiol (1973) 1.40
Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res (2001) 1.36
Black-gold: a simple, high-resolution histochemical label for normal and pathological myelin in brain tissue sections. Brain Res (1999) 1.27
Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth (2013) 1.26
Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest (1997) 1.25
The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther (1992) 1.23
Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J Pharmacol Exp Ther (2000) 1.23
Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr (1986) 1.21
Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem (2001) 1.20
Mass spectral characterization of doxylamine and its rhesus monkey urinary metabolites. Biomed Mass Spectrom (1985) 1.19
Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br J Clin Pharmacol (1984) 1.18
Smoking and passive smoking during pregnancy and early infancy: effects on birth weight, lactation period, and cotinine concentrations in mother's milk and infant's urine. Toxicol Lett (1987) 1.16
Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate (1986) 1.16
Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann N Y Acad Sci (2001) 1.16
Atopic diseases in infancy. The German multicenter atopy study (MAS-90). Pediatr Allergy Immunol (1994) 1.15
The amino acid sequence of a carboxypeptidase inhibitor from potatoes. Biochemistry (1975) 1.14
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett (2000) 1.14
Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res (1994) 1.13
Identification of bacterial proteins observed in MALDI TOF mass spectra from whole cells. Anal Chem (1999) 1.13
Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology (1992) 1.11
Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther (1981) 1.09
Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther (1995) 1.09
Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests. J Pharmacol Exp Ther (1988) 1.09
Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspect (1986) 1.08
Risk assessment for neurotoxic effects. Neurotoxicology (1990) 1.07
Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia (1992) 1.07
Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res (1998) 1.06
The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex. Neuroscience (2007) 1.06
Exposure of newborn infants to di-(2-ethylhexyl)-phthalate and 2-ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters. Transfusion (1993) 1.05
Accelerated cytomegalovirus retinitis secondary to immunosuppressive therapy. Arch Ophthalmol (1986) 1.05
Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome. Acta Paediatr (1996) 1.05
Potentiation of acetazolamide induced ectrodactyly in SWV and C57BL/6J mice by cadmium sulfate. Teratology (1984) 1.05
Gene expression profiling in the developing rat brain exposed to ketamine. Neuroscience (2010) 1.04
Ocular complications of Tangier disease. Am J Med (1987) 1.04
Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice. Neuropharmacology (1985) 1.04
Domoic acid-treated cynomolgus monkeys (M. fascicularis): effects of dose on hippocampal neuronal and terminal degeneration. Brain Res (1993) 1.03
Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet (1983) 1.02
THE QUANTITATIVE DETERMINATION OF VASOCONSTRICTOR SPASM AS A BASIS FOR THERAPY IN PERIPHERAL ARTERIAL DISEASES. Ann Surg (1932) 1.02
THE POSSIBILITY OF MALIGNANCY AS IT AFFECTS THE TREATMENT OF CHRONIC GASTRIC ULCER. Ann Surg (1935) 1.01
Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J Lipid Res (1990) 1.01
Legless, a novel mutation found in PHT1-1 transgenic mice. Science (1988) 1.00
Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther (1994) 1.00
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ (2006) 1.00
A dynamic analysis of migration: an assessment of the effects of age, family and career variables. Demography (1981) 1.00
Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice. Fundam Appl Toxicol (1992) 0.99
Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. Teratology (1999) 0.99
The clinical correlates of a 3' truncating mutation (codons 1982-1983) in the adenomatous polyposis coli gene. Gastroenterology (1997) 0.98
Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives. Mol Pharmacol (2001) 0.98
Comparison of the transplacental pharmacokinetics of 17 beta-estradiol and diethylstilbestrol in the subhuman primate. J Pharmacol Exp Ther (1982) 0.98
Manganese-induced reactive oxygen species: comparison between Mn+2 and Mn+3. Neurodegeneration (1995) 0.98
Serum ferritin concentration in Gaucher's disease. Br Med J (Clin Res Ed) (1983) 0.98
Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain. Int J Dev Neurosci (1995) 0.98
The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology (1998) 0.97
Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites. J Pediatr (1984) 0.97
SOME ANGIOSPASTIC SYNDROMES IN THE EXTREMITIES. Ann Surg (1931) 0.97
Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Neurotoxicology (1989) 0.96
MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels. Synapse (1994) 0.96
Incorporation of 3'-azido-3'-deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose. J Acquir Immune Defic Syndr (1999) 0.96
4-Methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-retinoic acid in the mouse. Arch Toxicol (1992) 0.96
Determination of phoxim residues in eggs by using high-performance liquid chromatography diode array detection after treatment of stocked housing facilities for the poultry red mite (Dermanyssus gallinae). Anal Chim Acta (2006) 0.96
Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia (1988) 0.95
Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia (1984) 0.95
Pentyl-4-yn-valproic acid enhances both spatial and avoidance learning, and attenuates age-related NCAM-mediated neuroplastic decline within the rat medial temporal lobe. J Neurochem (2001) 0.94
Placental transfer and metabolism of 17 alpha-ethynylestradiol-17 beta and estradiol-17 beta in the rhesus monkey. J Pharmacol Exp Ther (1982) 0.94
Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. Pediatr Pharmacol (New York) (1983) 0.94
Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res (2002) 0.94
Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice. Fundam Appl Toxicol (1986) 0.94
Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol Biochem Behav (1993) 0.93